The Prevalence of CYP2C8, 2C9, 2J2, and Soluble Epoxide Hydrolase Polymorphisms in African Americans With Hypertension | Zendy

A DREISBACH | Zendy; S. Japa | Zendy; A Sigel | Zendy; Marco Parenti | Zendy; Ann M. Hess | Zendy; SL Srinouanprachanh | Zendy; Allan E. Rettie | Zendy; Ho Kim | Zendy; Frederico M. Farin | Zendy; L. Lee Hamm | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Prevalence of CYP2C8, 2C9, 2J2, and Soluble Epoxide Hydrolase Polymorphisms in African Americans With Hypertension

Author(s) -

A DREISBACH,

S. Japa,

A Sigel,

Marco Parenti,

Ann M. Hess,

SL Srinouanprachanh,

Allan E. Rettie,

Ho Kim,

Frederico M. Farin,

L. Lee Hamm

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.04.019

Subject(s) - medicine , epoxide hydrolase , epoxide , biochemistry , enzyme , biology , catalysis , microsome

The cytochrome P450 (CYP) epoxygenase pathway produces arachidonic acid metabolites that are vasoactive, that affect renal sodium handling, and that have been proposed to play a mechanistic role in hypertension. Multiple single nucleotide polymorphisms (SNP) in CYP2C8, 2C9, 2J2 and soluble epoxide hydrolase (sEH) have been identified, many of which have altered functional activity in vitro. We performed a case-control study to determine the prevalence of epoxygenase-related SNP in African American individuals and to evaluate whether these SNP are associated with increased risk of hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research